Cetera Advisors LLC Trims Stake in Walgreens Boots Alliance Inc (NASDAQ:WBA)

Cetera Advisors LLC trimmed its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 1.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 23,847 shares of the pharmacy operator’s stock after selling 425 shares during the period. Cetera Advisors LLC’s holdings in Walgreens Boots Alliance were worth $1,316,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. NEXT Financial Group Inc increased its stake in shares of Walgreens Boots Alliance by 27.8% in the 2nd quarter. NEXT Financial Group Inc now owns 2,663 shares of the pharmacy operator’s stock worth $145,000 after purchasing an additional 580 shares in the last quarter. First National Bank of South Miami increased its stake in shares of Walgreens Boots Alliance by 3.0% in the 2nd quarter. First National Bank of South Miami now owns 10,386 shares of the pharmacy operator’s stock worth $566,000 after purchasing an additional 303 shares in the last quarter. Synovus Financial Corp increased its stake in shares of Walgreens Boots Alliance by 3.6% in the 2nd quarter. Synovus Financial Corp now owns 16,177 shares of the pharmacy operator’s stock worth $883,000 after purchasing an additional 555 shares in the last quarter. H D Vest Advisory Services purchased a new stake in shares of Walgreens Boots Alliance in the 2nd quarter worth $236,000. Finally, Cornerstone Advisors Inc. increased its stake in shares of Walgreens Boots Alliance by 131.6% in the 2nd quarter. Cornerstone Advisors Inc. now owns 894 shares of the pharmacy operator’s stock worth $49,000 after purchasing an additional 508 shares in the last quarter. Hedge funds and other institutional investors own 60.44% of the company’s stock.

Several research firms have recently commented on WBA. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, November 6th. Deutsche Bank started coverage on Walgreens Boots Alliance in a research note on Thursday, September 12th. They issued a “sell” rating for the company. Pivotal Research cut their price target on Walgreens Boots Alliance from $60.00 to $55.00 and set a “hold” rating for the company in a research note on Wednesday, October 30th. Morgan Stanley cut their price target on Walgreens Boots Alliance from $61.00 to $58.00 and set an “equal weight” rating for the company in a research note on Friday, August 23rd. Finally, JPMorgan Chase & Co. lowered Walgreens Boots Alliance from an “overweight” rating to a “neutral” rating and cut their price target for the stock from $73.00 to $63.00 in a research note on Wednesday, October 23rd. Five equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and two have assigned a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus price target of $61.35.

Shares of WBA stock opened at $62.14 on Friday. Walgreens Boots Alliance Inc has a 52-week low of $49.03 and a 52-week high of $86.31. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.36 and a current ratio of 0.73. The firm has a market capitalization of $55.98 billion, a PE ratio of 10.37, a PEG ratio of 1.56 and a beta of 0.87. The stock has a fifty day simple moving average of $55.90 and a two-hundred day simple moving average of $53.76.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Monday, October 28th. The pharmacy operator reported $1.43 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.41 by $0.02. The firm had revenue of $33.95 billion during the quarter, compared to analyst estimates of $33.88 billion. Walgreens Boots Alliance had a return on equity of 21.99% and a net margin of 2.91%. The business’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter last year, the business posted $1.48 earnings per share. On average, sell-side analysts forecast that Walgreens Boots Alliance Inc will post 5.93 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Stockholders of record on Monday, November 18th will be given a dividend of $0.458 per share. The ex-dividend date is Friday, November 15th. This represents a $1.83 dividend on an annualized basis and a dividend yield of 2.95%. Walgreens Boots Alliance’s payout ratio is 30.55%.

In other news, CAO Marco Patrick Anthony Pagni sold 234,355 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $63.16, for a total transaction of $14,801,861.80. Following the completion of the transaction, the chief accounting officer now owns 13,844 shares in the company, valued at $874,387.04. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 15.73% of the company’s stock.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

Featured Story: How to read a candlestick chart

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.